Fecke et al., 1998 - Google Patents
Expression of factor I‐resistant mutants of the human complement component C3 in heterologous systemsFecke et al., 1998
- Document ID
- 5797344404713193358
- Author
- Fecke W
- Farries T
- D'Cruz L
- Napper C
- Harrison R
- Publication year
- Publication venue
- Xenotransplantation
External Links
Snippet
Complement plays a major role in hyperacute rejection of xenografts. In order to overcome this, we are developing, by minimal mutagenesis, a modified C3 molecule that, like cobra venom factor (CVF), escapes normal complement regulatory processes and inhibits …
- 230000000295 complement 0 title abstract description 29
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3253064B2 (en) | Human rhinovirus receptor protein blocks viral infectivity | |
| Steck | The band 3 protein of the human red cell membrane: a review | |
| JP6033531B2 (en) | Compositions and methods for diagnosing and treating disorders associated with angiogenesis | |
| Patel et al. | A fibronectin matrix is required for differentiation of murine erythroleukemia cells into reticulocytes. | |
| US5340727A (en) | GPIbα fragments and recombinant DNA expression vectors | |
| JP2002238587A (en) | Secretory and transmembrane polypeptide, and nucleic acid encoding the same | |
| JP2004000009A (en) | New polypeptide and nucleic acid encoding the same | |
| JP2000511782A (en) | Antigenic fusion protein having GALα1,3GAL epitope | |
| JPH02503744A (en) | Part VIII: Improved production method of factor c type protein | |
| JP2001512668A (en) | Lipocalin homolog | |
| JP2004506413A (en) | Compositions and methods for diagnosis and treatment of diseases involving angiogenesis | |
| WO2006103258A1 (en) | Method for improved isolation of recombinantly produced proteins | |
| JP2007014346A (en) | Method and composition for inhibiting neoplastic cell growth | |
| US5922320A (en) | Recombinant proCVF | |
| JP2004507201A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding them | |
| JP4300286B2 (en) | Solubilized complement receptor type 1 crystals | |
| Fecke et al. | Expression of factor I‐resistant mutants of the human complement component C3 in heterologous systems | |
| US5521071A (en) | Soluble LDL receptor and gene | |
| Javitch et al. | Expression and characterization of human dopamine D2 receptor in baculovirus-infected insect cells | |
| HUP9903789A2 (en) | von Willebrand factor derivative and method for protein isolation | |
| JP3922390B2 (en) | Method for producing high-purity solubilized complement receptor type 1 (sCR1) | |
| DE69932266T2 (en) | Secreted and transmembrane polypeptide and nucleic acid coding therefor | |
| AU772759B2 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
| TW529953B (en) | Preparation of human recombinant erythropoietin and it's stabilized solution | |
| Strous et al. | Expression of functional growth hormone receptor in a mouse L cell line infected with recombinant vaccinia virus |